Scope
Reference
C341339
Description
NHS England has published this Preliminary Market Engagement Notice for the Licence variation: spironolactone for acne in women. It is anticipated that there will be two separate contracts to deliver this, as outlined below. • Contract A: Prepare an application for a major (type II) MHRA Marketing Authorisation variation for spironolactone. • Contract B: Submit the pre-prepared application to the MHRA. Only current Marketing Authorisation Holders of spironolactone are eligible to bid for contract B. To register an interest in responding to this market engagement exercise and obtain a copy of the Request for Information documentation please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis.
Total value (estimated)
- £0 excluding VAT
- £0 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 September 2025 to 1 July 2027
- 1 year, 10 months, 1 day
Main procurement category
Services
CPV classifications
- 85100000 - Health services
Engagement
Engagement deadline
14 March 2025
Engagement process description
NHS England would like to gather soft intelligence from the market and is publishing a Request for Information for the two contracts. NHS England would also be pleased to offer 1:1 meetings with potential Suppliers to discuss this innovative partnership approach. The Request for Information and further documentation will be available from 25 February 2025 and the deadline for responses and 1:1 meetings will be 12 noon on 11 March 2025.
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
2 May 2025
Contracting authority
NHS England, Leeds
- Public Procurement Organisation Number: PDPT-3135-BWWY
7&8 Wellington Place
Leeds
LS1 4AP
United Kingdom
Region: UKE42 - Leeds
Organisation type: Public authority - central government